Elsevier (NYSE:RUK) (NYSE:ENL) (Amsterdam:REN) (LSE:REL), the leading
publisher of scientific, technical and medical information, announced
today that Brian Nairn, CEO of Elsevier Health Sciences, is retiring
from the company. Michael Hansen, the former CEO of Harcourt Assessment
Inc., has been appointed to succeed Nairn and will report to Erik
Engstrom, Elsevier´s CEO; effective June 9th.
Nairn will remain with the company during a transition period.
Erik Engstrom said of Brian´s retirement, "I
would like to thank Brian for his dedication to the company during his
eight years as CEO of Elsevier Health Sciences. In this time the
division has more than doubled in revenue, has consistently outperformed
the competition and is executing on an exciting segment-based growth
strategy."
Michael Hansen brings extremely relevant experience to his new role. He
recently served as CEO of Harcourt Assessment formerly owned by Reed
Elsevier. He was previously with Bertelsmann, as EVP of Operational
Excellence. He started his career at The Boston Consulting Group in New
York, where he became a Partner and Chairman of the global Media
Convergence practice and was a senior member of the firm´s
health care practice.
Michael said of the appointment, "I´m
very proud to join a company that is so uniquely positioned to improve
the quality and performance of healthcare delivery worldwide. Brian has
developed a powerful team that is driving a rapid growth program in
Elsevier Health Sciences. I am very much looking forward to working with
them to build on this record of success."
Hansen holds a law degree from the University of Bonn in Germany and an
MBA from Columbia University in New York.
###
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with
the global science and health communities, Elsevier´s
7,000 employees in over 70 offices worldwide publish more than 2,000
journals and 1,900 new books per year, in addition to offering a suite
of innovative electronic products, such as ScienceDirect (http://www.sciencedirect.com/)
MD Consult (http://www.mdconsult.com/)
Scopus (http://www.info.scopus.com/)
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/)
is a global business headquartered in Amsterdam, The Netherlands and has
offices worldwide. Elsevier is part of Reed Elsevier Group plc (http://www.reedelsevier.com/)
a world-leading publisher and information provider. Operating in the
science and medical, legal, education and business-to-business sectors
Reed Elsevier provides high-quality and flexible information solutions
to users, with increasing emphasis on the Internet as a means of
delivery. Reed Elsevier´s ticker symbols are REN (Euronext Amsterdam)
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
